According to FutureWise analysis the market for cytogenetics in 2023 is US$ 2.62 billion, and is expected to reach US$ 5.5 billion by 2031 at a CAGR of 9.72%.
The study of chromosomes in cells and tissues is known as cytogenetics. This research will be used to better understand genetic illnesses such as cancer, sickle cell anaemia, cystic fibrosis, Down's syndrome, and others in biology and medicine. In addition, cytogenetics is employed in the creation of personalised medicine, cancer treatment, and other fields. For the screening of genetic abnormalities and malignancies, a variety of techniques such as comparative genomic hybridization, fluorescence in situ hybridization, karyotyping, and others are now used. These methods make use of cytogenetic goods including kits, medium, and reagents, among other things. The rise in the incidence of genetic disorders and cancer is propelling the worldwide cytogenetics market forward. Increased focus on targeted cancer therapy, an ageing population, and an increase in the prevalence of chronic diseases are all factors driving market expansion. The high cost of cytogenetic tools, on the other hand, is impeding industry growth. In contrast, the global market is predicted to benefit from the shift from fluorescence in situ hybridization to array-based technology. Furthermore, new products such as Cytocell Aquarius, a cost-effective fluorescence in situ hybridization (FISH) kit for the reliable analysis of glial tumours, were announced by Sysmex Corporation's subsidiary, Oxford Gene Technology.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Cytogenetics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Cytogenetics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.